Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 24633648)

1.

Current status and future perspectives on alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Khouzam RN, Naidu SS.

Curr Cardiol Rep. 2014 May;16(5):478. doi: 10.1007/s11886-014-0478-3. Review.

PMID:
24633648
2.

Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Sorajja P, Binder J, Nishimura RA, Holmes DR Jr, Rihal CS, Gersh BJ, Bresnahan JF, Ommen SR.

Catheter Cardiovasc Interv. 2013 Jan 1;81(1):E58-67. doi: 10.1002/ccd.24328. Epub 2012 Apr 17.

PMID:
22511295
3.

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.

Alam M, Dokainish H, Lakkis N.

J Interv Cardiol. 2006 Aug;19(4):319-27. Review.

PMID:
16881978
4.

Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile.

Jensen MK, Prinz C, Horstkotte D, van Buuren F, Bitter T, Faber L, Bundgaard H.

Heart. 2013 Jul;99(14):1012-7. doi: 10.1136/heartjnl-2012-303339. Epub 2013 May 3.

PMID:
23644300
5.

The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy.

Samardhi H, Walters DL, Raffel C, Rateesh S, Harley C, Burstow D, Pohlner P, Aroney C.

Catheter Cardiovasc Interv. 2014 Feb;83(2):270-7. doi: 10.1002/ccd.25134. Epub 2013 Aug 31.

PMID:
23873660
7.

Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.

Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ.

J Am Coll Cardiol. 2007 Jan 23;49(3):350-7. Epub 2007 Jan 4.

8.

Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Sorajja P, Ommen SR, Holmes DR Jr, Dearani JA, Rihal CS, Gersh BJ, Lennon RJ, Nishimura RA.

Circulation. 2012 Nov 13;126(20):2374-80. doi: 10.1161/CIRCULATIONAHA.111.076257. Epub 2012 Oct 17.

9.

Is surgery the gold standard in the treatment of obstructive hypertrophic cardiomyopathy?

Knyshov G, Lazoryshynets V, Rudenko K, Kravchuk B, Beshlyaga V, Zalevsky V, Rasputnyak O, Batsak B.

Interact Cardiovasc Thorac Surg. 2013 Jan;16(1):5-9. doi: 10.1093/icvts/ivs352. Epub 2012 Sep 30.

10.
11.

Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a European multicenter and multinational study.

Veselka J, Lawrenz T, Stellbrink C, Zemanek D, Branny M, Januska J, Sitar J, Dimitrow P, Krejci J, Dabrowski M, Mizera S, Bartel T, Kuhn H.

Catheter Cardiovasc Interv. 2014 Jul 1;84(1):101-7. doi: 10.1002/ccd.25236. Epub 2013 Nov 7.

PMID:
24285605
12.

Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution.

ten Cate FJ, Soliman OI, Michels M, Theuns DA, de Jong PL, Geleijnse ML, Serruys PW.

Circ Heart Fail. 2010 May;3(3):362-9. doi: 10.1161/CIRCHEARTFAILURE.109.862359. Epub 2010 Mar 23.

13.

Delayed occurrence of complete heart block after ethanol septal ablation for hypertrophic obstructive cardiomyopathy.

Poyet R, Quilici J, Cuisset T, Bali L, Ansaldi S, Prévost S, Habib G, Bonnet JL.

Int J Cardiol. 2011 Mar 3;147(2):e32-4. doi: 10.1016/j.ijcard.2009.01.048. Epub 2009 Feb 20.

PMID:
19232758
14.

Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.

Cuoco FA, Spencer WH 3rd, Fernandes VL, Nielsen CD, Nagueh S, Sturdivant JL, Leman RB, Wharton JM, Gold MR.

J Am Coll Cardiol. 2008 Nov 18;52(21):1718-23. doi: 10.1016/j.jacc.2008.07.061.

15.

Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry.

Nagueh SF, Groves BM, Schwartz L, Smith KM, Wang A, Bach RG, Nielsen C, Leya F, Buergler JM, Rowe SK, Woo A, Maldonado YM, Spencer WH 3rd.

J Am Coll Cardiol. 2011 Nov 22;58(22):2322-8. doi: 10.1016/j.jacc.2011.06.073.

16.

Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population.

Veselka J, Krejčí J, Tomašov P, Zemánek D.

Eur Heart J. 2014 Aug 7;35(30):2040-5. doi: 10.1093/eurheartj/eht495. Epub 2014 Jan 24.

PMID:
24464834
17.

Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy.

Smedira NG, Lytle BW, Lever HM, Rajeswaran J, Krishnaswamy G, Kaple RK, Dolney DO, Blackstone EH.

Ann Thorac Surg. 2008 Jan;85(1):127-33.

PMID:
18154797
18.

Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.

Kuhn H, Lawrenz T, Lieder F, Leuner C, Strunk-Mueller C, Obergassel L, Bartelsmeier M, Stellbrink C.

Clin Res Cardiol. 2008 Apr;97(4):234-43. Epub 2007 Dec 10.

PMID:
18071624
19.

Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score.

Ralph-Edwards A, Woo A, McCrindle BW, Shapero JL, Schwartz L, Rakowski H, Wigle ED, Williams WG.

J Thorac Cardiovasc Surg. 2005 Feb;129(2):351-8.

PMID:
15678046
20.

Survival of patients ≤ 50 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Veselka J, Krejčí J, Tomašov P, Jahnlová D, Honěk T, Januška J, Branny M, Zemánek D.

Can J Cardiol. 2014 Jun;30(6):634-8. doi: 10.1016/j.cjca.2014.03.041. Epub 2014 Apr 3.

PMID:
24882534
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk